HSPA9 and ovarian carcinoma: Low concentrations of PDTC could significantly inhibit NF‐κB and mortalin expression in A2780S cells, whereas higher concentrations were needed in A2780CP cells, suggesting that NF‐κB may be associated with ovarian cancer cell drug resistance.